Principaux concurrents
Rendement du dividende (Y) Rendement du dividende (Y+1) PER (Y) Price to Book (Y) VE / CA (Y) VE / EBITDA (Y) VE / EBIT (Y) Capi.($)
0,63%0,71%16.14x1.88x3.5x9.43x10.34x 63,56 Md
0,56%0,57%28.16x4.25x5.74x16.78x20.89x 55,92 Md
-.--%-.--%34.47x6.92x11.67x22.1x25.95x 41,68 Md
3,59%3,68%-42.72x2.33x3.04x9x10.5x 39,12 Md
-.--%-.--%34.89x1.72x3.71x11.39x13.25x 30,97 Md
-.--%-.--%-8.11x4.75x11.55x-7.09x-6.71x 28,77 Md
-.--%-.--%16.45x3.29x3.12x9.45x9.37x 22,74 Md
-.--%0,06%50.09x5.07x5.51x38.17x35.26x 17,64 Md
-.--%-.--%25.55x3.64x5.31x14.24x19.75x 16,66 Md
-.--%-.--%-34.23x-5.94x15.9x-48.35x-50.25x 14,6 Md
-.--%-.--%-124.18x12964.51x12.67x-112.25x-123.34x 12,38 Md
0,14%0,15%66.05x26.93x40.19x56.84x58.62x 12,37 Md
-.--%-.--%16.25x - 3.48x12.76x15.29x 11,18 Md
-.--%-.--%48.21x - - - - 10,95 Md
2,85%3,29%11.78x1.03x1.8x7.27x9.74x 6,11 Md
1,68%1,86%13.36x1.23x2.3x6.03x7.2x 5,38 Md
-.--%-.--%-102.47x - - - - 5,27 Md
Moyenne 0,56% 0,61% 2,92x 930,12x 8,63x 3,05x 3,72x 23,25 Md
Moyenne pondérée par Capi. 0,61% 0,64% 10,09x 440,28x 7,39x 7,68x 9,06x
Biopharmacies